Antiviral therapy use of p-glycoprotein modulators

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/495 (2006.01) A61K 31/195 (2006.01) A61K 31/20 (2006.01) A61K 31/205 (2006.01) A61K 31/22 (2006.01) A61K 31/24 (2006.01) A61K 31/34 (2006.01) A61K 31/445 (2006.01) A61K 31/47 (2006.01) A61K 31/50 (2006.01) A61K 38/55 (2006.01)

Patent

CA 2378984

The present invention relates to a pharmaceutical composition comprising a 10, 11 methanodibenzosuberane and use thereof for the treatment of HIV infection. Co-administration of the 10, 11 methanodibenzosuberane with an HIV protease inhibitor increases the concentration of the protease inhibitor in certain tissues, including the brain and testes, without substantially increasing plasma levels of the protease inhibitor. Accordingly, additional antiviral therapy can be achieved without use of increased drug dosages, thereby reducing the potential for occurrence of undesirable side effects deriving from drug toxicity.

L'invention concerne une composition pharmaceutique comprenant un 10, 11 méthanodibenzosubérane, et l'utilisation de cette composition pour le traitement de l'infection à VIH. L'administration conjointe de ce 10, 11 méthanodibenzosubérane et d'un inhibiteur de protéase VIH permet d'augmenter la concentration de l'inhibiteur de protéase dans certains tissus, notamment dans le cerveau et dans les testicules, sans augmenter de manière notable les concentrations plasmiques de l'inhibiteur de protéase. On peut ainsi mettre en oeuvre un traitement antiviral complémentaire sans augmentation des dosages des médicaments, ce qui permet de réduire le risque d'effets secondaires liés à la toxicité des médicaments.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Antiviral therapy use of p-glycoprotein modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antiviral therapy use of p-glycoprotein modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiviral therapy use of p-glycoprotein modulators will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1795278

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.